We identified a highly significant improvement in two-year uncensored and death-censored graft survival in the IL-2 plus group compared with the IL-2 minus group (Figures 1 and 2 ).
← all excerpts
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study.
1
—
—